International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 4 : 771-774
Case Report
Turbulent Journey of a Monogenic Lupus- A Case Report
 ,
 ,
 ,
 ,
 ,
 ,
 ,
 ,
Received
June 5, 2026
Accepted
June 25, 2026
Published
July 10, 2026
Abstract

Systemic Lupus Erythematosus(SLE) is a chronic autoimmune condition characterised by multisystemic inflammation and presence of circulating autoantibodies directed against self antigens. Though occurs both in children and adults, disproportionately females of reproductive age group are more affected. Monogenic lupus on the other hand has early age of onset along with distinct features including atypical manifestations of underlying disease such as immunodeficiency, immune dysregulation, refractory disease course.

We describe a 7 year old female who presented to us with fever, difficulty in breathing, livedo reticularis rash, generalised swelling of body over a span of 10 days. On Examination pallor, mucositis, generalised lymphadenopathy, hepatosplenomegaly, Previous history was suggestive of three admissions in past. First starting at 3 years of age for fever and mucocutaneous ulceration, resolved with supportive management. Six months apart two more admissions for pneumonia and stroke respectively. Child was on anti seizure medication and anti platelet agent.

Considering early onset of the disease, multisystemic involvement, unexplained fever, mucocutaneous involvement, livedo reticularis rash-provisional diagnosis of early onset lupus(monogenic) was made. Significant investigations like positive ANA, Chest X ray showing cardiomegaly and bilateral pulmonary infiltrates(pneumonia, heart failure), previous MRI, MRA Brain(CNS vasculitis) supported the diagnosis. However Whole Exome Sequencing could not be sent because of limited resources. Treatment with Intravenous pulse methyl prednisolone along with Intravenous antibiotics and other supportive measures. By third day of hospital stay unfortunately, the child required ionotropic and respiratory support, shifted to ICU and succumbed same day.

Despite aggressive treatment the child could not be saved mandating focus on strong suspicion of the disease right from its onset in order to narrow down gap between symptoms and diagnosis. This may help in satisfying outcomes of rare yet fatal disease like monogenic lupus.

Keywords
INTRODUCTION

SLE is a complex autoimmune disease with multisystemic involvement characterised by loss of self tolerance, more of autoantibody formation and immune complex formation. The term ‘Monogenic Lupus’ is used to describe group of patients with SLE or SLE-like symptoms with a proven underlying pathogenic variant. Those variants are grouped into four major pathways-

  1. Complement protein defects
  2. Endonuclease gene defects
  3. IFN-1 pathways
  4. B-& T- cell dysregulation

Combinedly they are called as Interferonopathies. Clinical Features of Monogenic Lupus include-

1. Young age at onset

2. Neurologic features- Spasticity

Acute or subacute Dystonia

Encephalopathy with seizures & progressive microcephaly Cortical Blindness

Developmental Delay Ataxia

Psychoses Stroke

Demyelinating or multifocal neuropathies

3. Skin features- Chilblains

Livedo reticularis Panniculitis Lentigenes Psoriasis

Sparse hair, Nail dystrophy

4. Failure to thrive

5. Immune dysregulation-Recurrent fever

6. Hematologic- Dyserythropoesis(Anemia)

Thrombocytopenia Malignancy(leukemia, lymphoma)

7. Pulmonary- Interstitial Lung Disease

Intraalveolar hemorrhage

8. Vascular – Calcification of aorta and other blood vessels

9. Musculoskeletal- Joint pain, arthritis

Contractures and joint retractions

Myositis

10. Ophthalmologic- Glaucoma

11. Kidney- Lupus Nephritis

12. Gastrointestinal- Very Early Onset IBD

13. Dental Anomalies- Retained primary teeth

Premature loss of permanent teeth

 

CASE PRESENTATION

A 7 year old female admitted to our hospital with a ten days history of fever, difficulty in breathing, livedo reticularis rash, generalised swelling of body.

 

In past, at the age of 3 years the child had first presentation of fever for 2 weeks on and off for 1 week with some facial rash, resolved with some oral medications.

 

Six months later child presented to another institute with acute onset weakness and 2 episodes of unprovoked seizure-treated in line of Stroke with antiplatelet agent and anti-seizure medication which was continued till this presentation.

Eight months later, the child had been admitted to another institute for Pneumonia with a stay for 6 days, discharged.

Child was unable to attend school because of disability and also had loss of appetite.

 

On Examination

Figure 1 – Chilblain,           Figure 2- Livedo Reticularis and joint contractures (spasticity)

 

Figure 3- Alopecia               Figure 4- mucocutaneous ulcers

 

Generalised wasting present.

Alopecia present. Mucocutanous lesions(oral ulcers, healed discoid lesions over nasolabial region) present. Hyperpigmented skin.

 

Pallor, Livedo reticularis rash,chilblains, anasarca present.

Febrile, Tachypnea, Tachycardia with hypoxia in room air(92% in room air) while blood pressure maintained.

Higher Mental Function-Alert, oriented, poor attention, memory intact, executive function and abstract thinking diminished.

 

Spasticity and joint contractures present bilaterally, more on left upper and lower limbs.

Deep tendon reflexes exaggerated while superficial reflex – plantar showed extensor response. Power diminished left>right muscle groups of both upper and lower limbs.

 

No active convulsion. No meningeal signs. Respiratory – bilateral diffuse crepts present Cardiovascular- muffled heart sounds with no murmur

 

Abdomen- soft, Hepato splenomegaly(liver span-12cm, spleen-7 cm), slit like umbilicus.

We made a Provisional diagnosis of “Monogenic Lupus with Pneumonia in Congestive Cardiac Failure with CNS vasculitis”.

 

Supporting investigations -

CBC- Hb 7.8 MCV 81, MCH 28.9 MCHC 35.5

TLC 11610 N 73.4 L 19.6 M 5.1 E1.4

TPC 3.5

CRP(Q)- 84mg/dl

 

ESR-100mm/hr

SGPT/SGOT/Serum Albumin/Total bilirubin-78/58/2/1.2

Serum Urea/Creatinine- 48/1.1

Urine Routine Microscopy- Albumin 1+

Chest X ray – B/L pulmonary patchy infiltrates with cardiomegaly

2D ECHO- LV Dysfunction, Ejection Fraction-38%, mild Pericardial effusion

MRI, MRA Brain- CNS Vasculitis

ANA positive

 

During Hospital stay, IV methyl prednisolone was started at 20mg/kg/day along with IV Antibiotics. Anti seizure medication was continued. Iv ionotropes were required on day 2 of stay. Shifted to ICU because of worsening hemodynamic instability and mechanical ventilation support. Unfortunately the child succumbed in ICU on third day of hospitalisation.

 

DISCUSSION

Ubiquotously expressed inflammatory polypeptides induced by viral and microbial nucleic acids are type 1 interferons. Altered regulation of Interferon signalling causes unique clinical syndromes classified as interferonopathies. Characteristic phenotype being recurrent fevers, early onset skin vasculopathy(chilblains, livedo reticularis, panniculitis, lipodystrophy), ILD with fibrosis, encephalopathic CNS involvement and spasticity.

 

Our case discussed got fit into almost all domains of monogenic lupus, yet to regret it was too late to modify the disease to hault the fatality.

 

Thus early suspicion strongly based on the characteristic skin presentation, unexplained fever, multisystemic involvement with a young onset can lead to early diagnosis, appropriate investigations and early start of disease targeted therapy such that the disease takes a modified journey with favourable outcomes.

 

REFERENCES

  1. Kliegman RM, Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, editors. Nelson Textbook of Pediatrics. Vol 1. 22nd ed. Philadelphia: Elsevier; 2024.
  2. Lo Monogenic Lupus. Curr Rheumatol Rep. 2016;18(12):71.
  3. Alperin JM, Ortiz-Fernández L, Sawalha Monogenic Lupus: A Developing Paradigm of Disease. Front Immunol. 2018;9:2496.
  4. Charras A, Hiraki LT, Lewandowski L, Hedrich Genetic and epigenetic factors shape phenotypes and outcomes in systemic lupus erythematosus – focus on juvenile-onset systemic lupus erythematosus. Curr Opin Rheumatol. 2025;37(2):149-163.
  5. Morán-Álvarez P, et Monogenic systemic lupus erythematosus onset in a 13-year-old boy with Noonan like-syndrome: a case report and literature review. Pediatr Rheumatol. 2024;22:17.
  6. Almlöf JC, Nystedt S, Leonard D, et al. Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus. Hum Genet. 2019;138(2):141-150.
Recommended Articles
Research Article Open Access
Diagnostic Performance of Pipelle Endometrial Sampling in Perimenopausal Women with Abnormal Uterine Bleeding: A Prospective Observational Study
2026, Volume-7, Issue 4 : 775-780
Research Article Open Access
The Contributions of Greek and Arab Scholars in the Advancement of Neuroscience: A Comprehensive Analysis
2026, Volume-7, Issue 4 : 711-719
Research Article Open Access
The Correlation between Type 2 Diabetes Mellitus and Hypothyroidism: A Cross-Sectional Study
2026, Volume-7, Issue 1 : 3764-3770
Research Article Open Access
Effect of Coconut Water on Renal Parameters After Dichlorvos Toxicity in Albino Rats
2026, Volume-7, Issue 4 : 737-741
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 4
Citations
8 Views
3 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved